Endologix Announces FDA Approval of First Percutaneous Indication for Endovascular Abdominal Aortic Aneurysm Repair

[at noodls] – IRVINE, Calif., April 16, 2013 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has received U.S. Food and … more

View todays social media effects on ELGX

View the latest stocks trending across Twitter. Click to view dashboard

See who Endologix is hiring next, click here to view